Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
Clinical trial NCT01448720 · COMPLETED
Trial details
- NCT number
- NCT01448720
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.